PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Immunol. Author manuscript; available in PMC 2010 January 15.
Published in final edited form as:
PMCID: PMC2621318
NIHMSID: NIHMS78187

Increased Reactivity of Dendritic Cells from Aged Subjects to Self-Antigen, the Human DNA

Abstract

Diminished immune functions and chronic inflammation are hallmarks of aging. The underlying causes are not well understood. In this investigation, we show an increased reactivity of dendritic cells from aged subjects to self-antigens as one of the potential mechanism contributing to age-associated inflammation. Consistent with this, DCs from aged subjects display increased reactivity to intracellular human DNA, a self-antigen, by secreting enhanced quantities of type I interferon and Interleukin-6 compared to the DCs from young subjects. Furthermore, this is accompanied by an increased upregulation of costimulatory molecules CD80 and CD86. These DNA primed DCs from aged subjects enhanced T cell proliferation compared to the young subjects further substantiating our findings. Investigations of signaling mechanisms revealed that DNA-stimulated DCs from aged subjects displayed a significantly higher level of interferon regulatory factor-3 and NF-kappaB activity compared to their young counterparts. More importantly, DCs from aged subjects displayed a higher level of NF-kappaB activation at the basal level suggesting an increased state of activation. This activated state of DCs may be responsible for their increased reactivity to self-antigens such as DNA, which in turn contributes to the age-associated chronic inflammation.

Keywords: Human, Dendritic cells, Transcription factors, inflammation, signal transduction

INTRODUCTION

Immunosenescence is characterized by a decline in immune functions and chronic inflammation (1, 2). They are also the major causes of morbidity and mortality associated with increased age. Atherosclerosis, diabetes, Parkinson’s disease, Alzheimer’s disease and arthritis, which are characterized by a marked inflammatory component are diseases prevalent in the elderly (3). The mechanisms underlying the decline in immune functions and chronic inflammation associated with aging are poorly understood. Accumulating evidences suggest a critical role of the innate immune cells, such as dendritic cells (DCs), in generating inflammatory and tolerogenic responses.

Dendritic cells are the key regulators of the immune system coordinating both immunity and tolerance. They are present at various portals of entry of pathogens like skin, airways etc. forming a network of antigen presenting cells, ready to initiate and amplify immune responses. DCs present at these sites capture antigens, migrate to the lymphoid organs, and mature en route. During maturation they lose their antigen capturing capacity and upregulate the expression of MHC and costimulatory molecules, thus becoming the efficient antigen presenting cells (4). Under steady state conditions, immature DCs continuously sample the self-antigens from apoptotic cells in the periphery leading to T cell tolerance without costimulation. However, upon stimulation with microbial products, inflammatory cytokines or CD40 ligation, DCs begin to mature and migrate to the draining lymph nodes. Maturation of DCs is associated with phenotypic changes, including upregulation of costimulatory molecules and MHC, and secretion of IL-12 transforming them into fully functional antigen presenting cells (APC) (4, 5). These fully matured DCs are capable of stimulating T cells and B cells. Dendritic cells are thus critical for immune defense and any alteration in DC functions with age would compromise the proper functioning of the immune system.

Majority of prior studies in both mice (6, 7) and humans (8, 9) indicate that the immune responses are preserved in aged DCs. However, virtually nothing is known about the age-associated alterations in the capacity of DCs to maintain tolerance. Our previous studies had revealed that DCs from aged are impaired in their capacity to phagocytose apoptotic cells when compared to DCs from young (10). This would result in the accumulation of apoptotic cells leading to secondary necrosis and release of self-antigens such as DNA. Earlier studies from our laboratory have also shown that DCs from aged humans secrete increased quantities of pro-inflammatory cytokines in response to TLR ligands (10). This tendency of DCs from aged to secrete enhanced levels of pro-inflammatory cytokine may not be restricted to foreign antigens but may also exist for self-antigens, which will contribute to the age-associated chronic inflammation. In the present study, we have compared the reactivity of DCs from aged and young subjects for a self-antigen, the human DNA. Our data show increased reactivity of aged DCs to human DNA.

MATERIALS AND METHODS

Blood donors

Blood was collected from healthy elderly (65–90 years of age) and young (20–35 years of age) volunteer donors. Elderly subjects were of middle-class socio-economic status and are living independently. An extensive medical history was obtained to exclude individuals with any major diseases. None of these volunteers had any significant medical illness. Young, healthy subjects, matched for the gender were drawn from students, staff, and blood donors at the University of California, Irvine. The Institutional Review Board of the University of California, Irvine, approved this study.

Human DNA Preparation

DNA was isolated from human blood using Qiamp DNA Blood Midi Kit from Qiagen (Valencia, CA). RNase was added to remove RNA contamination. Purity and yield of DNA was measured by UV spectrophotometer. Preparations with 260/280 ratio above 1.9 were used for the experiments. The preparation was free of endotoxin contamination as determined by LAL test (Lonza Corp.).

DC activation

Monocyte derived dendritic cells (DCs) from aged and young subjects were prepared using GMCSF and IL-4 essentially as described (10, 11). Such DCs are of myeloid origin. Transfection reagent Lipofectamine 2000 (Invitrogen, Carlsbad, CA) was used to deliver human DNA to DCs. DNA was mixed with lipofectamine (lipo) in 100 μl of Opti-MEM for 20 minutes at room temperature, according to the protocol recommended by the manufacturer and added to 4×105 DCs in 300μl of RPMI medium containing 10% FCS. Final concentration of the DNA was 1μg/ml. Cell viability was unaffected by this treatment. 24h later cells were harvested and stained for surface markers CD40, CD80, CD86, CD83 and HLA-DR using directly conjugated antibodies (BD Pharmingen, San Jose, CA). Analysis was performed using the Flow jo software (Treestar Inc, Ashland, OR).

IFN-α (PBL Biomedicals, Piscatway, NJ) and IL-6 (BD Pharmingen) in the supernatants were measured by specific ELISA kits as per the manufacturer’s protocol.

Activation of DCs by apoptotic cells

Peripheral blood mononuclear cells (PBMCs) from healthy individuals were serum-starved overnight. Next day apoptosis was induced by exposing the cells to UV irradiation, at a dose of 80 mJ/cm2 in a UV Cross linker (Fisher Scientific). Irradiated cells were cultured in serum free medium at 37°C in 5% CO2 for another 24h. At thistime, approximately 75% of the cells were in late apoptotic stage and 25% were early apoptotic as determined by Annexin V and propidium iodide staining. DCs from aged and young and subjects were incubated with these apoptotic cells for 24h. The upregulation of costimulatory markers was determined by flow cytometry as described above. Supernatants collected were assayed for cytokines IL-6, TNF-α and IFN-α by ELISA.

Flow cytometry staining of Signaling molecules

The expression of phosphorylated p65 unit of NFκB in DCs was determined by FACS as described (10). DCs from aged and young subjects were stimulated for 0 and 3h with DNA+Lipo, fixed in phosflow buffer I (BD Biosciences) for 10 min at 37°C. Permeabilization was done with freshly prepared 90% ice-cold methanol for 30 min on ice and then cells were stained with the specific antibody for p65.

IRF-3 and NFκB activation

DCs from aged and young were stimulated with DNA for 3h. Cytoplasmic and nuclear fractions were prepared using the nuclear extract kit (Active Motif, Carlsbad, CA). Protein concentration was estimated using the Bio Rad reagent. IRF-3 and NFκB-p65 binding to DNA to activate transcription was determined in the nuclear fraction using Trans AM ELISA kits (Active Motif) as per the manufacturer’s protocol. The results were normalized to protein levels.

Microscopy

DNA was labeled with Alexa Fluor 594 using ARES DNA Labeling Kit (Invitrogen). Labeled DNA (1μg/ml) +Lipo were added to DCs grown on poly L-lysine coated coverslips for 3h–18h. DCs were permeabilized (PBS/1% FBS/0.1% saponin) and stained with FITC-labeled anti-LAMP-2 (BD Biosciences) antibodies.

Statistical analysis

Statistical analysis was done by using graph pad prism software. Students’t test or Wilcoxon signed rank test was used to measure significance. Values of p < 0.05 were considered significant.

RESULTS

DCs from aged subjects display increased reactivity to intracellular human DNA compared to DCs from young subjects

Our earlier studies led us to hypothesize that increased reactivity of DCs from aged to self-antigens may be one of the contributing factors to age-associated chronic inflammation. In the present study, we compared the reactivity of DCs from aged and young subjects to human DNA as a model self-antigen. Briefly, human DNA (1μg/ml) was delivered inside the human myeloid DCs from aged and young subjects using Lipofectamine 2000 (lipo) (Invitrogen, Carlsbad, CA). This dose of DNA was optimal for activation of DCs. Studies with DCs from both aged and young subjects show that higher concentrations of DNA is toxic while lower doses led to sub-optimal activation as determined by secretion of IFN-α and IL-6 (supplementary Figure 1). Intracellular delivery of DNA led to activation of DCs as determined by upregulation of costimulatory molecules CD80 and CD86 and secretion of cytokines IFN-α and IL-6 (Figure 1A and B). CD40, HLA-DR and the maturation marker CD83 did not display significant (p>0.05) upregulation in response to intracellular human DNA. More importantly, DCs from aged subjects displayed increased activation compared to DCs from young subjects. The upregulation of costimulatory molecules CD80 and CD86 was significantly higher (p<0.05) in DCs from aged subjects when compared to DCs from young (Figure 1A). The secretion of IFN-α (p=.0002) and IL-6 (p=0.04) was also significantly higher in DCs from aged as compared to DCs from young in response to intracellular human DNA (Figure 1B). There was no secretion of TNF-α, IL-12p40, IL-12p70 and IL-10 as determined by ELISA. Introduction of lipo alone did not activate DCs. Stimulatory activity of the DNA was lost when delivered without lipo suggesting that exposure to DNA alone does not induce activation of DCs and that this requires its intracellular delivery. In summary, intracellular mammalian DNA led to partial maturation of DCs and induced the secretion of IFN-α and IL-6. Remarkably, DCs from aged subjects showed significantly increased reactivity toward human DNA compared to DCs from young subjects.

Figure 1
DCs from aged subjects display increased reactivity to intracellular human DNA compared to DCs from young subjects

DCs from aged subjects are more reactive to late apoptotic cells relative to DCs from young subjects

Under normal physiological conditions, apoptotic cells are rapidly and efficiently cleared by macrophages and DCs without induction of inflammation. However, inefficient clearance of apoptotic cells, as observed in aging leads to accumulation of late apoptotic cells that undergo secondary necrosis resulting in the release of self antigens such as HSPs and DNA that may gain entry into the DCs to activate them. Intracellular delivery of self, human DNA by transfection to DCs was used to mimic this physiological condition. However, to confirm if the increased reactivity of DCs from aged to self-antigens exists even when DCs are exposed to them under physiological conditions, DCs from aged and young subjects were incubated with the late phase apoptotic cells at a ratio of (1:2) for 24 hours. This led to a significantly higher upregulation (p<0.05) of CD80 and CD86 on DCs from aged as compared to DCs from young (Figure 2A). This increased activation of DCs from aged was also reflected in cytokine levels. The level of cytokines IFN-α, IL-6 and TNF-α was significantly higher (p<0.05) in the supernatants of DCs from aged exposed to late apoptotic cells as compared to supernatants from exposed DCs from young subjects (Figure 2B). These findings suggest that DCs from aged are more reactive to self-antigens than DCs from young subjects and their increased reactivity to human DNA is not an artifact of the artificial delivery system.

Figure 2
DCs from aged subjects display increased reactivity to late apoptotic cells

DCs from aged subjects stimulate increased T cell proliferation upon activation with human DNA as compared to DCs from young

Next we determined if these human DNA activated DCs were capable of inducing proliferation of T cells. For this purpose, DCs from aged and young individuals were activated with human DNA for 24 hours as described in figure 1. DCs were washed and cultured with allogeneic, magnetic bead purified; CFSE labeled T cells from young subjects for five days and proliferation was determined by measuring the dilution of CFSE dye by flow cytometry. Titrating doses of DCs (10,000-100) were used for the experiments. DCs from young induced significantly higher (p<0.05) level of T cell proliferation compared to DCs from aged subjects in both stimulated and unstimulated groups. However, human DNA-stimulated DCs from aged induced significantly higher (p<0.05), proliferation of T cells (approximately 4% higher) as compared to unstimulated DC and lipo stimulated DCs without DNA from the aged subjects (Figure 3A). In contrast, human DNA-stimulated DCs from young subjects did not increase T cell proliferation relative to unstimulated young DC controls (Figure 3A). Secretion of IFN-γ correlated with the proliferation data. Akin to proliferation, IFN-γ levels were overall lower in the aged compared to the young subjects in all groups (Figure 3B). However, IFN-γ levels were significantly higher (p<0.05) in the Lipo+DNA-stimulated group compared to unstimulated and lipo stimulated DCs in the aged subjects (Figure 3B). Similar to proliferation, IFN-γ levels were comparable in DNA stimulated and unstimulated DCs from young subjects (Figure 3B) at all doses of DCs. These data further substantiate our findings that DCs from aged are more activated compared to young in response to human DNA.

Figure 3
DCs from aged subjects stimulate T cell proliferation upon activation with human DNA as compared to DCs from young

Intracellular human DNA localizes in the cytosol

To investigate the mechanisms responsible for the increased reactivity of DCs from aged to human DNA, first we determined the distribution of the intracellular DNA in the DCs. Red labeled DNA was found to localize in the cytosol after delivery. The picture was similar at all time points tested (3h, 8h–18h, Figure 4A). No co-localization of DNA was observed with the lysosomal marker, lysosome-associated membrane protein 2 (LAMP-2) suggesting that DNA does not enter the lysosomes (Figure 4A).

Figure 4
Intracellular human DNA localizes in the cytosol A

The presence of DNA in the cytosol suggests that it may be utilizing a cytosolic sensor of DNA. Recent studies have identified DAI (DNA-dependent activator of IFN-regulatory factors, also known as DLM-1/ZBP-1) as a cytosolic receptor that senses both foreign and self DNA (12, 13). We determined if age-associated increased expression of this receptor is responsible for the increased reactivity of DCs from aged to human DNA. The expression of DAI in DCs was comparable between the aged and young individuals both at the gene and protein levels (Figure 4B and C).

Increased activation of IRF-3 transcription factor in DCs from aged in response to Intracellular human DNA

Next, we investigated the signaling pathways activated in DCs in response to human DNA. Recent reports suggest an involvement of Interferon Regulatory Factors (IRFs) particularly IRF-3 (14) and IRF-7 (13) in IFN-α secretion via cytosolic DNA sensors (12). Therefore, we determined whether IRF-3 and IRF-7 are activated in response to human, DNA in DCs. DNA-binding activity of IRF-3 was assessed using a transcription factor ELISA kit for IRF-3 according to the manufacturer’s protocol. This kit measures the binding of IRF-3 to consensus DNA binding sequences, which activate transcription Significant activity (p<0.05) of IRF-3 was observed in the DNA activated group at three hours post stimulation compared to unstimulated controls (Figure 5). Earliest IRF-3 activity was detected two hours after addition of DNA, peaked at about 3 hours and declined to baseline level by 4–5 hours (data not shown). More importantly, IRF-3 activity was significantly increased (p<0.05) in DC from aged exposed to human DNA as compared to DCs from young exposed to human DNA (Figure 4). Basal level of IRF-3 activation was not significantly different (p>0.05) between the aged and young subjects. No phosphorylation of p38, AKT or IRF-7 was observed at all time points tested (data not shown). Increased activation of IRF-3 in DNA-treated DCs from aged may thus account for an enhanced secretion of IFN-α.

Figure 5
Increased activation of IRF-3 transcription factor in DCs from aged in response to Intracellular human DNA

DCs from aged display a higher basal level of NF-κB activation indicating an activated state

Besides IRFs, NF-κB signaling pathway is also reported to be activated by intracellular DNA sensing (12, 15). It has been shown that IRF-3 is activated by ds-B-DNA through the NF-κB dependent signaling pathway (16). Moreover, members of the NF-κB family of transcription factors p50, p52, p65 (RelA), c-Rel, and RelB are expressed at relatively high level in DCs (17). To varying degrees, the NF-κB transcription factors are associated with DC development, maturation, and functions. Therefore, to further understand the mechanisms of increased activation of DCs from aged to human DNA, we determined the activation of p65 subunit of NF-κB signaling pathway using flow cytometry and transcription factor ELISA assay. Our studies revealed that there was an increased activation of the p65 subunit of NF-κB at 3 hours post activation with DNA (Figure 6A). Furthermore, the level of activation of p65 at the basal level and after activation with DNA was significantly higher (p<0.05) in DCs from aged subjects compared to young subjects (Figure 5A). These data were further confirmed with flow cytometry (Figure 6B and C) by determining the phosphorylation of the p65 subunit using specific antibodies.

Figure 6
DCs from aged display a higher basal level of NFκB activation indicating an activated state

The predominant form of inducible NF-κB in APCs is considered to be the p50/p65 heterodimer. However, p50 subunit cannot initiate transcription since it does not contain a DNA-binding sequence. To further investigate a role of NF-κB in the activation of DCs by human DNA we utilized a cell-permeable, specific, peptide inhibitor, NF-κB SN50 (18) (Biomol Research Laboratories, Plymouth, PA) that inhibits the translocation of p50 unit to the nucleus preventing the formation of active p50/p65 heterodimers. Addition of the SN50 inhibitor (50μg/ml) to human DNA-stimulated DCs resulted in complete inhibition of p65 phosphorylation compared to both control peptide (SN50m) treated and no peptide treated human DNA-stimulated DCs (Figure 6D). Furthermore, addition of the inhibitor resulted in a significant inhibition (p<0.05) of IFN-α and IL-6 secretion from human DNA-stimulated DCs (Figure 6E). No inhibition in the production of these cytokines was observed using a control peptide at the same concentration (Figure 5E). These data suggests that increased level of NF-κB activation in DCs from aged may be responsible for their increased reactivity to human DNA.

DISCUSSION

Aging is considered a state of chronic inflammation, which is believed to be underlying cause of several diseases and mortality associated with aging (19). However, the mechanisms responsible for chronic inflammation in aging are not well understood. In addition, aging is also associated with increased reactivity to self antigens as evidenced by the presence of auto-antibodies to a variety of self antigens (2022). Here we show that DCs from aged display increased reactivity to human DNA, resulting in increased pro-inflammatory cytokine production and induction of T cell proliferation.

The immune system is normally protected from exposure to self dsDNA during apoptosis due to the rapid engulfment of apoptotic cells, and the abundance of extra- and intracellular DNases (23, 24). However, phagocytic cells may be exposed to cellular DNA following tissue necrosis, inflammation, or viral infection. Defective clearance of apoptotic cells would also result in an accumulation of late phase apoptotic cells. Previous study from our laboratory in humans (10) and a recent study (22) in mice suggest that apoptotic cell clearance is decreased with age. The late phase apoptotic cells are associated with additional proteolytic degradation of specific autoantigens, which may release endogenous danger signals like nuclear structures clustered in apoptotic blebs (chromatin and dsDNA) and proteins such as heat shock proteins (HSPs) causing maturation of dendritic cells resulting in T cell immunity to self (2426). Our results indicate that intracellular human DNA delivered via transfection agents such as lipofectamine can stimulate DCs to secrete cytokine and upregulate costimulatory molecules. This is in keeping with recent studies where intracellular mammalian DNA delivered via fugene (27) stimulated murine bone marrow derived dendritic cells to mature and secrete IFN-α. Intracellular administration of double-stranded B-form DNA (B-DNA) also triggered antiviral responses, including production of type I interferons and chemokines (16). Furthermore, macrophages from mouse embryos deficient in DNase II contain intracellular undigested DNA that causes lethal type I IFN production (28). Mammalian DNA or RNA complexed with antibodies, RNA binding proteins or antimicrobial peptides are also able to activate APCs to secrete type I IFNs (2931) and have been shown to be involved in autoimmune disorders such as systemic lupus erythromatous (32).

We have previously reported that DCs from aged secreted increased levels of pro-inflammatory cytokines TNF-α and IL-6 in response to TLR ligands (10). Present results show that this enhanced pro-inflammatory cytokine secretion by DCs from aged is not restricted to TLR ligands but is also seen with self-antigens such as human DNA (Figure 1A and B). There is increased upregulation of costimulatory molecules CD80 and CD86 and enhanced secretion of IFN-α and IL-6 by DCs from aged donors in response to self-DNA. These results are further substantiated by our findings that DCs from aged also show increased response to late apoptotic cells (Figure 2A & B). Activation of DCs with apoptotic cells resulted in the secretion of TNF-α along with IFN-α and IL-6. Apoptotic cells contain other self-antigens besides DNA such as HSPs, HMGBP1 that can stimulate DCs. This may be responsible for the observed TNF-α secretion.

Activation of DCs converts them into fully functional APCs capable of priming T cell responses. We show that human DNA-activated DCs from aged primed T cells to proliferate (Figure 3A) while the less activated DCs from young did not induce T cell proliferation (Figure 3A). The levels of IFN-γ in the DNA stimulated DCs from aged subjects was also significantly above (p<0.05) the unstimulated DCs while no such difference was observed in IFN-γ secretion from young subjects. Previous studies have reported that priming of T cells by DCs requires optimal level of co-stimulation as well as cytokine production (33) and this may account for the increased proliferation of T cell observed in the aged. Though the DNA-stimulated DCs from aged display increased capacity to prime T cells compared to their young counterparts, nevertheless overall they displayed reduced level of T cell proliferation (Figure 3A) compared to the young subjects. This supports previous report where reduced alloimmunity was observed in aged mice compared to young mice during solid organ transplant (34). However, the reasons for this are presently unclear. We have observed the same phenomenon in other experiments and the underlying mechanisms are being investigated. One of the possible mechanisms may be the impaired formation of DC-T cell synapse in aging.

Earlier studies with intracellular DNA delivered via transfection reagents have shown that DNA signals through non-TLR receptors (16, 27). This is in agreement with our results in that the DNA was localized in the cytosol (Figure 3A) and was not accessible to intracellular TLRs in the endosomes. The nucleic acid sensing TLR3 and TLR8 are found in the endosomes (35). The two other known nucleic acid sensing TLRs, TLRs 7 and 9 are not expressed in human monocyte derived DCs and are also present in the endosomes (36).

Furthermore, we did not find any difference in the expression of DAI (Figure 3B and C), one of the cytosolic DNA sensors identified recently. However, we did find activation of IRF-3 and phosphorylation of p65 unit of NF-κB signaling pathway, both of which are reported to be activated downstream of DAI (13). IRF-3 activity was significantly higher in the DNA-treated DCs from aged compared to young (Figure 4). Since IRF-3 is involved in the production of IFN-α (11), it may explain the increased secretion of IFN-α in DCs from aged. The phosphorylation of p65 was also significantly enhanced in the DCs from aged subjects (Figure 5A, B and C). However, in contrast to IRF-3, the basal level of p65 activation was significantly higher in DCs from aged suggesting that DCs in aged are in an activated state compared to young counterparts. Abrogation of cytokine secretion by NFκB inhibitor (Figure 5E) lent further support to this hypothesis. The activated state of DCs in aged subjects could be due to factors in the aged microenvironment such as increased pro-inflammatory cytokines that may cause the activation of DCs resulting in their increased reactivity to human DNA. Our previous studies had revealed no significant difference in the phenotype of DCs from aged and young (8, 10). Nevertheless, it was possible that DCs were not fully activated to manifest a mature phenotype but may still be primed or semi-activated. The phagocytic capacity of DCs decreases as they become activated and we have reported that DCs from aged are impaired in their capacity to phagocytose antigens (10). Earlier studies from our laboratory have also shown that the expression of PTEN protein, which negatively regulates the PI3kinase signaling pathway, is increased in DCs from aged. This leads to increased activation of p38 MAP kinase and enhanced secretion of pro-inflammatory cytokines (10) in response to TLR ligands. PI3kinase also regulates the activation of NF-κB pathway (37). Increased PTEN expression in aged may thus account for the increased level of NF-κB activation in DCs. This semi-activated state of DCs alters the response of DCs to antigens resulting in the secretion of increased level of cytokines.

In summary, we show that DCs from aged are more reactive to human DNA and secrete increased level of pro-inflammatory cytokines. Increased reactivity to self may result in impaired tolerance and thus be one of the mechanisms of age-associated chronic inflammation and autoimmunity. Recent reports indicate that there is enhanced basal level of activation in of NF-κB in DCs from rheumatoid arthritis patients (38). However, it remains to be determined whether similar mechanisms may be involved in other autoimmune diseases associated with increased pro-inflammatory cytokine production such as rheumatoid arthritis and systemic Lupus erythromatous.

Supplementary Material

PDF

Acknowledgments

The authors have no conflicting financial interests. We thank GCRC for providing the samples of young control subjects.

This study is supported in part by grant AG027512 from NIH and partly by new scholar grant from the Ellison Medical Foundation.

Abbreviations

IRF-3
Interferon regulatory factor -3
IRF-7
Interferon regulatory factor -7
DAI
DNA-dependent activator of IFN-regulatory factors, also known as DLM-1/zbp-1
Lipo
Lipofectamine

RERERENCES

1. Boren E, Gershwin ME. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev. 2004;3:401–406. [PubMed]
2. Effros RB. Ageing and the immune system. Novartis Found Symp. 2001;235:130–139. 139–145, 146–139. [PubMed]
3. Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am. 2003;23:15–39. [PubMed]
4. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245–252. [PubMed]
5. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol. 2003;21:685–711. [PubMed]
6. Tesar BM, Walker WE, Unternaehrer J, Joshi NS, Chandele A, Haynes L, Kaech S, Goldstein DR. Murine [corrected] myeloid dendritic cell-dependent toll-like receptor immunity is preserved with aging. Aging Cell. 2006;5:473–486. [PubMed]
7. Komatsubara S, Cinader B, Muramatsu S. Functional competence of dendritic cells of ageing C57BL/6 mice. Scand J Immunol. 1986;24:517–525. [PubMed]
8. Steger MM, Maczek C, Grubeck-Loebenstein B. Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals. Clin Exp Immunol. 1996;105:544–550. [PubMed]
9. Pietschmann P, Hahn P, Kudlacek S, Thomas R, Peterlik M. Surface markers and transendothelial migration of dendritic cells from elderly subjects. Exp Gerontol. 2000;35:213–224. [PubMed]
10. Agrawal A, Agrawal S, Cao JN, Su H, Osann K, Gupta S. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol. 2007;178:6912–6922. [PubMed]
11. Agrawal A, Kaushal P, Agrawal S, Gollapudi S, Gupta S. Thimerosal induces TH2 responses via influencing cytokine secretion by human dendritic cells. J Leukoc Biol. 2007;81:474–482. [PubMed]
12. Takaoka A, Taniguchi T. Cytosolic DNA recognition for triggering innate immune responses. Adv Drug Deliv Rev. 2008;60:847–857. [PubMed]
13. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, Ohba Y, Taniguchi T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature. 2007;448:501–505. [PubMed]
14. Stetson DB, Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity. 2006;24:93–103. [PubMed]
15. Wang Z, Choi MK, Ban T, Yanai H, Negishi H, Lu Y, Tamura T, Takaoka A, Nishikura K, Taniguchi T. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci U S A. 2008;105:5477–5482. [PubMed]
16. Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, Takeshita F, Ludwig H, Sutter G, Suzuki K, Hemmi H, Sato S, Yamamoto M, Uematsu S, Kawai T, Takeuchi O, Akira S. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol. 2006;7:40–48. [PubMed]
17. Wang J, Wang X, Hussain S, Zheng Y, Sanjabi S, Ouaaz F, Beg AA. Distinct roles of different NF-kappa B subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells. J Immunol. 2007;178:6777–6788. [PubMed]
18. Kuner P, Schubenel R, Hertel C. Beta-amyloid binds to p57NTR and activates NFkappaB in human neuroblastoma cells. J Neurosci Res. 1998;54:798–804. [PubMed]
19. McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci. 2004;1035:104–116. [PubMed]
20. Tomer Y, Shoenfeld Y. Ageing and autoantibodies. Autoimmunity. 1988;1:141–149. [PubMed]
21. Richaud-Patin Y, Villa AR. Autoantibodies, mortality and ageing. Med Hypotheses. 1995;44:10–15. [PubMed]
22. Aprahamian T, Takemura Y, Goukassian D, Walsh K. Ageing is associated with diminished apoptotic cell clearance in vivo. Clin Exp Immunol. 2008;152:448–455. [PubMed]
23. Stacey KJ, Young GR, Clark F, Sester DP, Roberts TL, Naik S, Sweet MJ, Hume DA. The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. J Immunol. 2003;170:3614–3620. [PubMed]
24. Okabe Y, Kawane K, Akira S, Taniguchi T, Nagata S. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J Exp Med. 2005;202:1333–1339. [PMC free article] [PubMed]
25. Nagata S, Nagase H, Kawane K, Mukae N, Fukuyama H. Degradation of chromosomal DNA during apoptosis. Cell Death Differ. 2003;10:108–116. [PubMed]
26. Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, Matoba H, Kohn LD, Klinman DM. Genomic DNA released by dying cells induces the maturation of APCs. J Immunol. 2001;167:2602–2607. [PubMed]
27. Martin DA, Elkon KB. Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll-like receptor 9-independent pathway. Arthritis Rheum. 2006;54:951–962. [PubMed]
28. Yoshida H, Okabe Y, Kawane K, Fukuyama H, Nagata S. Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat Immunol. 2005;6:49–56. [PubMed]
29. Savarese E, Chae OW, Trowitzsch S, Weber G, Kastner B, Akira S, Wagner H, Schmid RM, Bauer S, Krug A. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood. 2006;107:3229–3234. [PubMed]
30. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, Cao W, Wang YH, Su B, Nestle FO, Zal T, Mellman I, Schroder JM, Liu YJ, Gilliet M. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007;449:564–569. [PubMed]
31. Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad O, Coffman RL. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med. 2005;202:1131–1139. [PMC free article] [PubMed]
32. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet. 2000;25:177–181. [PubMed]
33. Curtsinger JM, Schmidt CS, Mondino A, Lins DC, Kedl RM, Jenkins MK, Mescher MF. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol. 1999;162:3256–3262. [PubMed]
34. Martins PN, Pratschke J, Pascher A, Fritsche L, Frei U, Neuhaus P, Tullius SG. Age and immune response in organ transplantation. Transplantation. 2005;79:127–132. [PubMed]
35. Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock DT. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol. 2004;5:190–198. [PubMed]
36. Ito T, Wang YH, Liu YJ. Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin Immunopathol. 2005;26:221–229. [PubMed]
37. Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol. 2003;24:358–363. [PubMed]
38. Pettit AR, MacDonald KP, O’Sullivan B, Thomas R. Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. Arthritis Rheum. 2000;43:791–800. [PubMed]